Vitamin A Metabolite Preserves T Cells’ Function as KAIST Points to a New Strategy for Treating Intractable Brain Tumors (IMAGE)

The Korea Advanced Institute of Science and Technology (KAIST)

Vitamin A Metabolite Preserves T Cells’ Function as KAIST Points to a New Strategy for Treating Intractable Brain Tumors

Caption

Figure 3. ATRA-Responsive CD8⁺ T-Cell Signatures Observed in Glioblastoma Patient Data

(a) Among patients treated with anti-PD-1 therapy, responders and non-responders were compared for ATRA-responsive gene signature scores and T-cell exhaustion scores. (b) Patient prognosis in glioblastoma was assessed according to the proportion of ATRA-responsive CD8⁺ T cells.

Credit

KAIST

Usage Restrictions

No

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.